MAPT and Alzheimer disease: In AD, Aβ aggregates to form fibrils and plaques in the brain,[3] and hyperphosphorylated tau aggregates to form neurofibrillary tangles.[4] Aβ, tau, and peptide fragments thereof have been used in peptide vaccine and immunotherapy development against AD.